Clinical Trials Logo

Sleep Disorders clinical trials

View clinical trials related to Sleep Disorders.

Filter by:

NCT ID: NCT01032473 Recruiting - Clinical trials for Generalized Anxiety Disorder

Mechanisms of Sleep Disturbance in Children With Generalized Anxiety Disorder (GAD)

Start date: August 2009
Phase: N/A
Study type: Observational

Anxiety disorders are among the most common mental disorders in children, affecting approximately 1 out of every 10 children and adolescents. Symptoms of anxiety disorders may include excessive fear/anxiety/worry, somatic complaints such as headaches and muscle aches, and impaired social and family relationships. Some children with anxiety also experience sleep problems, however, little is known about the sleep patterns of anxious children. The purpose of the study, conducted at Children's National Medical Center, is to examine the sleep characteristics of children with Generalized Anxiety Disorder (GAD) compared to a control group of children without GAD to see how sleep behaviors and daytime behaviors are related.

NCT ID: NCT01030939 Completed - Sleep Disorders Clinical Trials

Study to Investigate Safety, Tolerability, Pharmacokinetics and Cardiac Function After Repeat Doses of SB-649868 in Healthy-volunteers

Start date: August 27, 2009
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine whether SB-649868 is safe, tolerable after repeated administrations in adult and elderly healthy volunteers. Pharmacokinetics and effects on cardiac function of repeated doses are studied

NCT ID: NCT01024192 Completed - Sleep Disorders Clinical Trials

Efficacy and Safety Assessment of ZOlpidem (Stilnox CR) in Patients With Chronic insomNIA

Start date: November 2009
Phase: Phase 4
Study type: Interventional

Primary Objective: To evaluate the efficacy and safety of the use of Stilnox CR in Mexican patients with chronic insomnia at the prescription conditions of daily practice Secondary Objective: To evaluate the satisfaction of the patient with chronic insomnia with Stilnox CR over an as needed basis.

NCT ID: NCT00994279 Completed - Breast Cancer Clinical Trials

Yoga or Educational Wellness Class for Women With Stage I, Stage II, or Stage III Breast Cancer Undergoing Chemotherapy

Start date: January 2010
Phase: N/A
Study type: Interventional

RATIONALE: Yoga and wellness classes may reduce fatigue and improve mood, sleep, and quality of life in women receiving chemotherapy for breast cancer. It is not yet known whether yoga is more effective than wellness education for women with breast cancer who are undergoing chemotherapy. PURPOSE: This randomized phase II trial is studying a community-based yoga class to see how well it works compared with an educational wellness class for women with stage I, stage II, or stage III breast cancer undergoing chemotherapy.

NCT ID: NCT00993928 Terminated - Fatigue Clinical Trials

Home-Based Programs for Improving Sleep in Cancer Survivors

Start date: April 2010
Phase: Phase 2
Study type: Interventional

RATIONALE: Following a program that uses written materials and pre-recorded mp3 devices may help improve the sleep of cancer survivors. It is not yet known which home-based program is more effective in improving the sleep of cancer survivors. PURPOSE: This randomized phase II trial is comparing two home-based programs for improving sleep in cancer survivors.

NCT ID: NCT00993850 Completed - Bipolar Disorder Clinical Trials

Sleep Disturbance and Bipolar Disorder

Start date: October 2009
Phase: Phase 3
Study type: Interventional

The study aims to evaluate a psychological intervention for individuals who suffer from sleep disturbance and bipolar disorder. We are hoping that this treatment will: (1) improve the quality of life of individuals with bipolar disorder who are suffering from sleep disturbance and (2) reduce the risk of, or help prevent, episodes.

NCT ID: NCT00992160 Completed - Sleep Disorders Clinical Trials

Vestipitant 28-day Tolerance Study

Start date: May 2009
Phase: Phase 2
Study type: Interventional

This study is a 28-day polysomnographic and subjective assessment of oral Vestipitant 15mg/day for treatment of Primary Insomnia in adults outpatients.

NCT ID: NCT00990106 Completed - Clinical trials for Stress Disorders, Post-Traumatic

Augmentation Trial of Prazosin for Post-Traumatic Stress Disorder (PTSD)

Start date: September 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether prazosin will: - reduce the incidence of nightmares and sleep disturbance - increase functioning and sense of well being in combat-trauma exposed Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) Veterans.

NCT ID: NCT00989976 Completed - Diabetes Clinical Trials

Individual Differences in Diabetes Risk: Role of Sleep Disturbances

Start date: February 2009
Phase: N/A
Study type: Interventional

The hypothesis for this study is that some individuals may be at much higher risk to develop type 2 diabetes and that the individual diabetes risk will be predicted by the individual level of slow wave sleep activity (SWA).

NCT ID: NCT00988104 Completed - Clinical trials for Stress Disorders, Post-Traumatic

Preventing Long Term Psychiatric Disability Among Those With Major Burn Injuries

SMART
Start date: October 16, 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a newly developed, brief cognitive behavioral intervention, relative to supportive counseling, is effective in reducing acute stress disorder (ASD) and preventing post traumatic stress disorder (PTSD) and depression.